Questions for the Panel
Effectiveness of the System on Functional Status
Risk-Benefit of the System used for Destination Therapy
The HeartMate VE LVAS is indicated for use as a bridge to transplantation in cardiac transplant candidates at risk of imminent death from nonreversible left ventricular failure. The HeartMate VE LVAS is also indicated for use in patients with end-stage left ventricular failure who are ineligible for cardiac transplantation. The HeartMate VE LVAS is intended for use both inside and outside the hospital.